These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25917597)

  • 1. Diagnosing phenotypes of single-sample individuals by edge biomarkers.
    Zhang W; Zeng T; Liu X; Chen L
    J Mol Cell Biol; 2015 Jun; 7(3):231-41. PubMed ID: 25917597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edge biomarkers for classification and prediction of phenotypes.
    Zeng T; Zhang W; Yu X; Liu X; Li M; Liu R; Chen L
    Sci China Life Sci; 2014 Nov; 57(11):1103-14. PubMed ID: 25326072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EdgeMarker: Identifying differentially correlated molecule pairs as edge-biomarkers.
    Zhang W; Zeng T; Chen L
    J Theor Biol; 2014 Dec; 362():35-43. PubMed ID: 24931676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.
    Toh SH; Prathipati P; Motakis E; Kwoh CK; Yenamandra SP; Kuznetsov VA
    BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S24. PubMed ID: 22369099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals.
    Zeng T; Zhang W; Yu X; Liu X; Li M; Chen L
    Brief Bioinform; 2016 Jul; 17(4):576-92. PubMed ID: 26411472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
    Adnan N; Lei C; Ruan J
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
    Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction.
    Liang J; Li ZW; Sun ZN; Bi Y; Cheng H; Zeng T; Guo WF
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37833844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and early diagnosis of complex diseases by edge-network.
    Yu X; Li G; Chen L
    Bioinformatics; 2014 Mar; 30(6):852-9. PubMed ID: 24177717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual-level analysis of differential expression of genes and pathways for personalized medicine.
    Wang H; Sun Q; Zhao W; Qi L; Gu Y; Li P; Zhang M; Li Y; Liu SL; Guo Z
    Bioinformatics; 2015 Jan; 31(1):62-8. PubMed ID: 25165092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparameter analysis using cell cycle biomarkers for small-size lung adenocarcinoma: prognostic implications.
    Haruki T; Shomori K; Shiomi T; Taniguchi Y; Nakamura H; Ito H
    Oncol Rep; 2012 Sep; 28(3):915-22. PubMed ID: 22767360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
    Kadivar M; Boozari B
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum chemokine network correlates with chemotherapy in non-small cell lung cancer.
    Yang D; Zhou J; Zeng T; Yang Z; Wang X; Hu J; Song Y; Chen L; Peer D; Wang X; Bai C
    Cancer Lett; 2015 Aug; 365(1):57-67. PubMed ID: 25976768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
    Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
    Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.